Tous les communiqués de presse

- Increased momentum in the clinical newsflow for major indications: results expected in 2022 for prediabetes, hypercholesterolemia and high blood pressure.

Voir le communiqué de presse

- 10 December 2021 Ordinary General Meeting – Procedures for availability of preparatory documents (IN FRENCH).

Voir le communiqué de presse

- Update on the METEX NØØVISTA activity (IN FRENCH).

Voir le communiqué de presse

- Valbiotis announces positive preclinical results for TOTUM•070 in hypercholesterolemia, selected and presented at the American Heart Association (AHA) annual meeting.

Voir le communiqué de presse

- The Carbios Board appoints a new Executive Director as of 1 December 2021 (IN FRENCH).

Voir le communiqué de presse

- SABI AGRI and INRAE ​​unite their skills to design the robotic agricultural equipment of tomorrow thanks to the LabCom TIARA (IN FRENCH).

Voir le communiqué de presse

- First-quarter 2021 financial information (IN FRENCH).

Voir le communiqué de presse

- Valbiotis reviews its activities and publishes its financial report for the first half of 2021.

Voir le communiqué de presse

- Valbiotis consolidates its development of innovative natural health solutions by integrating the exploration of microalgae produced in New Caledonia, through an exclusive agreement with ADECAL-Technopole and IFREMER.

Voir le communiqué de presse

- Implementation of a production stabilization plan for the METEX NØØVISTA plant in Carling: Next PDO expedition at mid-November.

Voir le communiqué de presse